On June 12, 2025, Ellipsis Health, Inc. closed the transaction. The company has received $45 million co-led by new investors Salesforce, Inc., CVS Health Ventures, and returning investor, Khosla Ventures, LLC. The transaction included participation from the returning investors Mitsui & Co.

Global Investment Ltd., Colliers International Group Inc. E12 Venture Capital Fund I, L.P. the fund managed by E12 Venture Capital, AME Cloud Ventures, LLC.